Copyright
©The Author(s) 2025.
World J Nephrol. Sep 25, 2025; 14(3): 109400
Published online Sep 25, 2025. doi: 10.5527/wjn.v14.i3.109400
Published online Sep 25, 2025. doi: 10.5527/wjn.v14.i3.109400
Table 1 Laboratory results for the patient at the time of diagnosis up to 13 months
Day 0 | Day 10 | Day 40 | 3 months | 4 months | 9 months | 11 months | 13 months | |
Serum creatinine | 4 | 6.16 | 4.06 | 2.6 | 2.72 | 2.42 | 2.52 | 2.32 |
BUN | 57 | 141 | 61 | 46 | 47 | 46 | 40 | 38 |
uPCR | 1.7 | NA | NA | 1.91 | 3.28 | N/A | 0.84 | 1 |
Urine RBC (/hpf) | > 100 | 98 | 12 | 4 | 1 | N/A | 1 | 1 |
Anti-MPO | > 8 | NA | 6.3 | 3.4 | N/A | N/A | 0.4 | N/A |
P-ANCA | > 1:640 | NA | > 1:640 | < 1:20 | N/A | N/A | < 1:20 | N/A |
- Citation: Nguyen JT, Anand M. Avacopan in the treatment of relapsing polychondritis with myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis: A case report. World J Nephrol 2025; 14(3): 109400
- URL: https://www.wjgnet.com/2220-6124/full/v14/i3/109400.htm
- DOI: https://dx.doi.org/10.5527/wjn.v14.i3.109400